| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.
|
Gastroenterology
|
2005
|
6.34
|
|
2
|
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.
|
Cancer Res
|
2005
|
5.68
|
|
3
|
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
|
J Natl Cancer Inst
|
2006
|
3.08
|
|
4
|
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
|
Int J Cancer
|
2007
|
2.36
|
|
5
|
A comparison of colon and rectal somatic DNA alterations.
|
Dis Colon Rectum
|
2009
|
1.85
|
|
6
|
APC mutations and other genetic and epigenetic changes in colon cancer.
|
Mol Cancer Res
|
2007
|
1.54
|
|
7
|
MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype.
|
Genes Chromosomes Cancer
|
2010
|
1.51
|
|
8
|
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population.
|
Carcinogenesis
|
2012
|
1.40
|
|
9
|
Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.37
|
|
10
|
IL6 genotypes and colon and rectal cancer.
|
Cancer Causes Control
|
2007
|
1.36
|
|
11
|
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.
|
Carcinogenesis
|
2007
|
1.28
|
|
12
|
Microsatellite instability and survival in rectal cancer.
|
Cancer Causes Control
|
2009
|
1.24
|
|
13
|
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
|
Carcinogenesis
|
2010
|
1.19
|
|
14
|
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.
|
Mutat Res
|
2008
|
1.18
|
|
15
|
Increased risk of colon cancer associated with a genetic polymorphism of SMAD7.
|
Cancer Res
|
2010
|
1.17
|
|
16
|
Somatic alterations, metabolizing genes and smoking in rectal cancer.
|
Int J Cancer
|
2009
|
1.17
|
|
17
|
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
|
Genes Chromosomes Cancer
|
2013
|
1.16
|
|
18
|
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
|
Mol Carcinog
|
2011
|
1.16
|
|
19
|
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.15
|
|
20
|
Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
|
Int J Cancer
|
2011
|
1.12
|
|
21
|
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
|
Carcinogenesis
|
2010
|
1.11
|
|
22
|
The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.
|
Genes Chromosomes Cancer
|
2008
|
1.10
|
|
23
|
MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression.
|
Carcinogenesis
|
2016
|
1.08
|
|
24
|
MAP kinase genes and colon and rectal cancer.
|
Carcinogenesis
|
2012
|
1.08
|
|
25
|
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.
|
Carcinogenesis
|
2011
|
1.05
|
|
26
|
Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.
|
Mutat Res
|
2010
|
1.04
|
|
27
|
CDX2 VDR polymorphism and colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.04
|
|
28
|
Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions.
|
Int J Cancer
|
2008
|
1.04
|
|
29
|
Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors.
|
Genes Chromosomes Cancer
|
2009
|
1.03
|
|
30
|
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
|
Clin Gastroenterol Hepatol
|
2006
|
1.00
|
|
31
|
Active and passive smoking, IL6, ESR1, and breast cancer risk.
|
Breast Cancer Res Treat
|
2007
|
1.00
|
|
32
|
Genetic variation in bone morphogenetic protein and colon and rectal cancer.
|
Int J Cancer
|
2011
|
0.99
|
|
33
|
Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor.
|
BMC Med Genet
|
2010
|
0.99
|
|
34
|
Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.
|
Mutat Res
|
2012
|
0.99
|
|
35
|
Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
|
Breast Cancer Res Treat
|
2011
|
0.98
|
|
36
|
Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer.
|
Nutr Cancer
|
2006
|
0.97
|
|
37
|
VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
|
Mol Carcinog
|
2013
|
0.97
|
|
38
|
Tumor markers and rectal cancer: support for an inflammation-related pathway.
|
Int J Cancer
|
2009
|
0.97
|
|
39
|
Genetic admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study?
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.97
|
|
40
|
Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
|
PLoS One
|
2013
|
0.97
|
|
41
|
Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer.
|
Cancer Causes Control
|
2007
|
0.95
|
|
42
|
Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
|
Breast Cancer Res Treat
|
2012
|
0.95
|
|
43
|
Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes.
|
Cancer Causes Control
|
2010
|
0.94
|
|
44
|
Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
|
Breast Cancer Res Treat
|
2013
|
0.93
|
|
45
|
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.
|
Breast Cancer Res Treat
|
2011
|
0.92
|
|
46
|
Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.
|
Int J Cancer
|
2013
|
0.92
|
|
47
|
Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women.
|
Nutr Cancer
|
2011
|
0.92
|
|
48
|
Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.
|
Int J Mol Epidemiol Genet
|
2012
|
0.91
|
|
49
|
Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.90
|
|
50
|
Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
|
J Rheumatol
|
2013
|
0.90
|
|
51
|
Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer.
|
Nutr Cancer
|
2013
|
0.89
|
|
52
|
Variation in the CYP19A1 gene and risk of colon and rectal cancer.
|
Cancer Causes Control
|
2011
|
0.89
|
|
53
|
Interleukin genes and associations with colon and rectal cancer risk and overall survival.
|
Int J Cancer
|
2012
|
0.88
|
|
54
|
Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
|
Cancer
|
2011
|
0.88
|
|
55
|
Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.
|
Nutr Cancer
|
2010
|
0.86
|
|
56
|
The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2013
|
0.86
|
|
57
|
Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
|
Dis Colon Rectum
|
2012
|
0.86
|
|
58
|
Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
|
PLoS One
|
2012
|
0.86
|
|
59
|
TERT's role in colorectal carcinogenesis.
|
Mol Carcinog
|
2012
|
0.86
|
|
60
|
Tumor necrosis factor-related genes and colon and rectal cancer.
|
Int J Mol Epidemiol Genet
|
2011
|
0.85
|
|
61
|
Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations.
|
Int J Mol Epidemiol Genet
|
2010
|
0.85
|
|
62
|
Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer.
|
Mutat Res
|
2006
|
0.84
|
|
63
|
SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.
|
PLoS One
|
2013
|
0.84
|
|
64
|
Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk.
|
Obesity (Silver Spring)
|
2008
|
0.84
|
|
65
|
Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.
|
Breast Cancer Res Treat
|
2014
|
0.83
|
|
66
|
MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer.
|
Mol Carcinog
|
2009
|
0.82
|
|
67
|
Alcohol consumption and rectal tumor mutations and epigenetic changes.
|
Dis Colon Rectum
|
2010
|
0.82
|
|
68
|
Leptin and colorectal cancer: an undefined link.
|
Nat Clin Pract Gastroenterol Hepatol
|
2007
|
0.81
|
|
69
|
Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
|
Int J Mol Epidemiol Genet
|
2013
|
0.81
|
|
70
|
Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study.
|
Int J Cancer
|
2012
|
0.80
|
|
71
|
Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
|
Nutr Cancer
|
2011
|
0.80
|
|
72
|
Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.
|
Rheumatology (Oxford)
|
2014
|
0.79
|
|
73
|
Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.
|
Breast Cancer Res Treat
|
2013
|
0.78
|
|
74
|
Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2014
|
0.78
|
|
75
|
ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity.
|
Cancer Causes Control
|
2012
|
0.78
|
|
76
|
Dietary intake alters gene expression in colon tissue: possible underlying mechanism for the influence of diet on disease.
|
Pharmacogenet Genomics
|
2016
|
0.77
|
|
77
|
Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study.
|
Mutat Res
|
2014
|
0.77
|
|
78
|
Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2016
|
0.76
|
|
79
|
MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study.
|
Nutr Cancer
|
2015
|
0.76
|
|
80
|
Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome.
|
Exp Lung Res
|
2014
|
0.75
|
|
81
|
Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2014
|
0.75
|